関連する実験動画

Updated: Jul 10, 2026

LAD-Ligation: A Murine Model of Myocardial Infarction
08:23

LAD-Ligation: A Murine Model of Myocardial Infarction

Published on: October 14, 2009

45.1K

ドクソルビシンによる心筋損傷におけるグレリンとワートンのゼリー由来メゼンキマ幹細胞の単独および併用による心臓保護効果

Amy F Boushra1, Christina Sabry Yacoub1, Hamed Mohamed Osman2

  • 1Department of Medical Physiology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.

Journal of molecular histology
|August 29, 2025
PubMed
まとめ

No abstract available in PubMed .

キーワード:
心臓毒性ドクソルビシングレリンワートンゼリー由来メゼンキマ幹細胞 (WJ-MSCs)

さらに関連する動画

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.4K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.2K

関連する概念動画

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...